JFS Wealth Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198 Buy
+11
New +$154 ﹤0.01% 2151
2024
Q3
Sell
-17
Closed -$496 1987
2024
Q2
$496 Sell
17
-7
-29% -$208 ﹤0.01% 1809
2024
Q1
$851 Sell
24
-17
-41% -$680 ﹤0.01% 1693
2023
Q4
$1.79K Sell
41
-8
-16% -$315 ﹤0.01% 1483
2023
Q3
$1.87K Buy
49
+11
+29% +$463 ﹤0.01% 1383
2023
Q2
$1.56K Sell
38
-19
-33% -$914 ﹤0.01% 1476
2023
Q1
$3.27K Buy
57
+5
+10% +$282 ﹤0.01% 1166
2022
Q4
$2.92K Buy
52
+3
+6% +$153 ﹤0.01% 1220
2022
Q3
$2K Buy
49
+36
+277% +$1.84K ﹤0.01% 1336
2022
Q2
$1K Sell
13
-27
-68% -$1.62K ﹤0.01% 1548
2022
Q1
$3K Buy
40
+23
+135% +$1.51K ﹤0.01% 1257
2021
Q4
$1K Buy
+17
New +$1.15K ﹤0.01% 1403

Other funds holding IART

JFS Wealth Advisors's IART Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Integra LifeSciences (IART) in Q2 2026: 11 shares worth $198. The stake represents ﹤0.01% of the portfolio and ranks #2151 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in IART as recently as Q2 2024.

JFS Wealth Advisors first reported a position in IART in Q4 2021 and has held it in 12 quarters since. The position peaked at $3.27K in Q1 2023. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • JFS Wealth Advisors held 11 shares of Integra LifeSciences worth $198 as of Q2 2026.
  • Integra LifeSciences was a new JFS Wealth Advisors position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2151 holding.
  • JFS Wealth Advisors first reported a position in Integra LifeSciences in Q4 2021 and has held it in 12 quarters since.
  • JFS Wealth Advisors's Integra LifeSciences position peaked at $3.27K in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.